The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 15, No. 1, pp. 8-14.
© 1981 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKenney, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKenney, J.


Research Articles

Methods of modifying compliance behavior in hypertensive patients

JM McKenney

The cardinal features of patient compliance, as conceptualized in this article, are that medication-taking is a behavior, the decision to comply is a dynamic process, and compliance is a highly individualistic phenomenon. This individualization may be determined in part by specific health-related factors and inherent individual traits influencing the decision to comply. Thus, the practitioner who wishes to respond to compliance must offer strategies that are behaviorally oriented, tailored to the individual patient, and continuously applied. It is evident that compliance behavior is very complex and multifaceted. It is unlikely that any single compliance-improving strategy will adequately address the problem in all patients. Instead, combinations of techniques offered continuously over the span of the therapy are more likely to be successful. Finally, the common element that appears to run through all of the compliance studies is the attention given study patients by health workers. It may be that regardless of the specific techniques used, increasing attention to the compliance issue will help keep it in the forefront during decision-making and improve compliance behavior.


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
E. R. Port, L. L. Montgomery, A. S. Heerdt, and P. I. Borgen
Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary Prevention
Ann. Surg. Oncol., August 1, 2001; 8(7): 580 - 585.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1981 by Harvey Whitney Books Company.